Name Card

rp01466 picture

Professor Yau, Chung Cheung Thomas 邱宗祥

Title:

Clinical Associate Professor

Department:

Centre of Cancer Medicine

Faculty:

Li Ka Shing Faculty of Medicine

Publications - Articles

	Title	Author(s)	Issue Date
	The Hong Kong consensus recommendations on the diagnosis and management of pancreatic cystic lesions Journal:Hepatobiliary Surgery and Nutrition	Cheung, Tan-To Lee, Yuk Tong Tang, Raymond Shing-Yan She, Wong Hoi Cheng, Kai Chi Cheung, Chin Cheung Chiu, Keith Wan Hang Chok, Kenneth Siu Ho Chow, Wing Sun Lai, Tak Wing Seto, Wai-Kay Yau, Thomas	1-Oct-2023
	The Hong Kong consensus statements on unresectable hepatocellular carcinoma: narrative review and update for 2021 Journal:Hepatobiliary Surgery and Nutrition	Cheung, TT Yu, SCH Chan, SL Poon, RTP Kwok, P Lee, AS Tai, A Tam, D Cheung, CC Lai, TW Chia, NH Law, A Shum, T Lam, YK Lau, V Lee, V Chong, C Tang, CN Yau, T	1-Jun-2023
	Non-Neutralizing Epitopes Shade Neutralizing Epitopes against Omicron in a Multiple Epitope-Based Vaccine Journal:ACS Infectious Diseases	Gong, HR Hu, YF Li, XC Yau, TCC Zhang, BZ Huang, JD	10-Nov-2022
	CFI-402257, a TTK inhibitor, effectively suppresses hepatocellular carcinoma Journal:Proceedings of the National Academy of Sciences	Chan, Cerise Yuen-Ki Chiu, David Kung-Chun Yuen, Vincent Wai-Hin Law, Cheuk-Ting Wong, Bowie Po-Yee Thu, Kelsie Lynn Cescon, David Ward Soria-Bretones, Isabel Cheu, Jacinth Wing-Sum Lee, Derek Tse, Aki Pui-Wah Zhang, Misty Shuo Tan, Kel Vin Ng, Irene Oi-Lin Khong, Pek-Lan Yau, Thomas Chung-Cheung Bray, Mark Robert Mak, Tak Wah Wong, Carmen Chak-Lui	1-Aug-2022
	Polo‐like kinase 4 inhibitor CFI‐400945 suppresses liver cancer through cell cycle perturbation and eliciting antitumor immunity Journal:Hepatology	Chan, YK YUEN, WH Chiu, KC Goh, CC Thu, KL Cescon, DW Soria‐Bretones, I Law, CT CHEU, WS Lee, D Tse, PW Tan, KV Zhang, S WONG, PY Wong, CM Khong, PL Ng, IOL Bray, MR Mak, TW Yau, TCC Wong, CCL	2022
	Computation of Antigenicity Predicts SARS-CoV-2 Vaccine Breakthrough Variants Journal:Frontiers in Immunology	Hu, Y Hu, JC Gong, H Danchin, ALM Sun, R Chu, H Hung, FNI Yuen, KY To, KKW Zhang, BZ Yau, TCC Huang, J	2022
	In-Silico Analysis of Monoclonal Antibodies against SARS-CoV-2 Omicron Journal:Viruses	Hu, Y Hu, J Chu, H Yau, TCC Zhang, B Huang, J	2022
	The outcomes of systemic treatment in recurrent hepatocellular carcinomas following liver transplants Journal:Advances in Therapy	Li, BCW Chiu, J Shing, K Kwok, GGW Tang, V Leung, R Ma, KW She, WH Tsang, J Chan, A Cheung, TT Lo, CM Yau, T	2021
	Safety and tolerability of subcutaneous trastuzumab and intravenous pertuzumab as adjuvant treatment for HER2 positive breast cancer: a pilot study Journal:Postgrad Med J	Wong, CY Leung, RCY Kwok, GW Tsang, J Li, CW Yau, TCC Chiu, WYJ	2021
	Safety, efficacy, and pharmacodynamics of tremelimumab plus durvalumab for patients with unresectable hepatocellular carcinoma: Randomized expansion of a phase I/II study Journal:Journal of Clinical Oncology	Kelley, RK Sangro, B Harris, W Ikeda, M Okusaka, T Kang, YK Qin, S Tai, DWM Lim, HY Yau, T Yong, WP Cheng, AL Gasbarrini, A Damian, S Bruix, J Borad, M Bendell, J Kim, TY Standifer, N He, P Makowsky, M Negro, A Kudo, M Abou-Alfa, GK	2021

Loading Content...Please Wait!

Loading Content...Please Wait!